Company · CIK 1490978
Schrodinger, Inc.
| CIK | 1490978 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | NY |
| Listed | SDGR (Nasdaq) |
| First annual or quarterly report | 2020-03-16 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-277479 | 2024-02-28 | 2024-02-28 | 1 | |
| 333-253865 | 2021-03-04 | 2023-05-24 | 2 | |
| 333-243714 | 2020-08-10 | 2020-08-13 | 3 | |
| 333-235890 | 2020-01-10 | 2020-02-06 | 4 |
Filings
12| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2024-02-28 | S-3ASRShelf registered | 333-277479 | 0001193125-24-050978 |
| 2023-05-24 | 424B5Shelf takedown | 333-253865 | 0001193125-23-152947 |
| 2021-03-04 | S-3ASRShelf registered | 333-253865 | 0001193125-21-068578 |
| 2020-08-13 | 424B4Final prospectus | 333-243714 | 0001193125-20-219152 |
| 2020-08-12 | EFFECTDeclared effective | 333-243714 | 9999999995-20-002125 |
| 2020-08-10 | S-1Registration filed | 333-243714 | 0001193125-20-214928 |
| 2020-07-31 | DRSDraft made public | 377-03349 | 0000950123-20-007362 |
| 2020-02-06 | 424B4Final prospectus | 333-235890 | 0001193125-20-026787 |
| 2020-02-05 | EFFECTDeclared effective | 333-235890 | 9999999995-20-000259 |
| 2020-01-27 | S-1/AAmendment | 333-235890 | 0001193125-20-014624 |
| 2020-01-10 | S-1Registration filed | 333-235890 | 0001193125-20-005504 |
| 2019-10-30 | DRSDraft made public | 377-02882 | 0000950123-19-009817 |